STAT

Opinion: 5 tips for creating effective biotech partnerships

I've been on both sides of forging biotech partnerships. Here are five tips for creating good ones.

The J.P. Morgan Healthcare Conference is like the Olympics for biotechnology entrepreneurs. Every January, small companies with big ideas go for the gold: the chance to see their innovation, hard work, and talent recognized and rewarded with the resources they need to move forward.

As the show kicks off, entrepreneurs naturally focus on how to win the attention of major players who can offer the capital, scientific expertise, and development experience it takes to turn a promising innovation into a successful medicine — or, better yet, to completely change the way the industry thinks about therapy.

As someone who led small private and public biotechs before joining

You're reading a preview, sign up to read more.

More from STAT

STAT2 min readPolitics
House Votes To Overturn Trump Administration Ban On Fetal Tissue Research
House lawmakers on Thursday voted to overturn the Trump administration’s recent decision to ban federal funding for biomedical research involving human fetal tissue — a symbolic move on a partisan…
STAT3 min read
GSK Partners With CRISPR Pioneer Doudna To Search For New Drugs
CRISPR pioneer Jennifer Doudna and CRISPR researcher Jonathan Weissman will work with GlaxoSmithKline in a new Bay Area drug discovery lab.
STAT2 min readScience
Pfizer Spends $11.4 Billion To Buy Array BioPharma For Its Cancer Drug Chemistry
Pfizer said it will spend $11.4 billion in cash to purchase Array BioPharma, a Boulder, Colo.-based biotech known as a top choice among biotechnology firms that need to synthesize new…